Cargando…
Pharmacologic inducers of the uric acid exporter ABCG2 as potential drugs for treatment of gouty arthritis
Uric acid is the end product of purine catabolism and its plasma levels are maintained below its maximum solubility in water (6–7 mg/dl). The plasma levels are tightly regulated as the balance between the rate of production and the rate of excretion, the latter occurring in urine (kidney), bile (liv...
Autores principales: | Ristic, Bojana, Sikder, Mohd Omar Faruk, Bhutia, Yangzom D., Ganapathy, Vadivel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shenyang Pharmaceutical University
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193448/ https://www.ncbi.nlm.nih.gov/pubmed/32373197 http://dx.doi.org/10.1016/j.ajps.2019.10.002 |
Ejemplares similares
-
Hereditary hemochromatosis disrupts uric acid homeostasis and causes hyperuricemia via altered expression/activity of xanthine oxidase and ABCG2
por: Ristic, Bojana, et al.
Publicado: (2020) -
α-Methyl-l-tryptophan as a weight-loss agent in multiple models of obesity in mice
por: Sivaprakasam, Sathish, et al.
Publicado: (2021) -
SLC6A14, a Na(+)/Cl(−)-coupled amino acid transporter, functions as a tumor promoter in colon and is a target for Wnt signaling
por: Sikder, Mohd O. F., et al.
Publicado: (2020) -
Re-programming tumour cell metabolism to treat cancer: no lone target for lonidamine
por: Bhutia, Yangzom D., et al.
Publicado: (2016) -
Transporter-Guided Delivery of Nanoparticles to Improve Drug Permeation across Cellular Barriers and Drug Exposure to Selective Cell Types
por: Kou, Longfa, et al.
Publicado: (2018)